reports
Eik fasteignafélag hf.: Flöggun – Brimgarðar ehf.
Eik fasteignafélag hf.: Flöggun – Brimgarðar ehf. Flöggunartilkynning er í viðhengi. Viðhengi
Eik fasteignafélag hf.: Viðskipti nákomins aðila stjórnanda
Eik fasteignafélag hf.: Viðskipti nákomins aðila stjórnanda Sjá meðfylgjandi tilkynningar. Viðhengi
Dundee Precious Metals Annual and Special Meeting of Shareholders to b...
Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025 TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces its Annual and Special Meeting of Shareholders will be held on Wednesday, May 7, 2025, at 4 PM EDT via live audio webcast. Materials for the meeting, including a user guide for accessing the virtual meeting, are available on our website at: . Details of the Annual and Special Meeting of Shareholders, including a link to the audio webcast, are as follows: Webcast date and timeWednes...
Transactions In Connection with Share Buy-back Program
Transactions In Connection with Share Buy-back Program Company Announcement COPENHAGEN, Denmark; April 7, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025. The following transactions were executed under the program from March 31 to April 4, 2025: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)Accumula...
EQS-News: HIVE Digital gibt Bestromung und den Beginn des Betriebs am ...
EQS-News: HIVE Digital Technologies Ltd. / Schlagwort(e): Quartals-/Zwischenmitteilung HIVE Digital gibt Bestromung und den Beginn des Betriebs am Standort Yguazú sowie die Produktionsergebnisse im März 2025 bekannt 07.04.2025 / 13:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HIVE Digital Technologies gibt Bestromung und den Beginn des Betriebs am Standort Yguazú sowie die Produktionsergebnisse im März 2025 bekanntDiese Pressemitteilung ist eine „ausgewiesene Pressemitteilung“ im Sinne des Prospektnachtrags des Unternehmens vom ...
P10 Completes Acquisition of Qualitas Funds, a Leading European Lower-...
P10 Completes Acquisition of Qualitas Funds, a Leading European Lower-Middle Market Alternative Investment Solutions Provider DALLAS, April 07, 2025 (GLOBE NEWSWIRE) -- (NYSE: PX) (“P10” or the “Company”), a leading private markets solutions provider, today announced it has completed its previously announced acquisition of Qualitas Equity Funds SGEIC, S.A. (“Qualitas Funds”) for an initial purchase price of $63 million, with the potential for additional earnout consideration. Qualitas Funds is a Madrid-based private equity investing platform that provides fund-of-funds, direct co-inves...
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pedi...
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for effective treatmentsAJOVY is currently the only anti-CGRP treatment for migraine prevention in adults in the U.S. that is available in both quarterly and monthly dosing options1These efforts underscore Teva’s dedication to expanding access to...
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial R...
Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025 TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, May 15, 2025. Management will host a conference call at 8:00 a.m. Eastern Time on May 15, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to participate may d...
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medi...
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid MedicineLive and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it will host its 5th medical symposium on Cannab...
MariMed Promotes Ryan Crandall to Chief Commercial Officer
MariMed Promotes Ryan Crandall to Chief Commercial Officer NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- . (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, ...
NFI schedules release of first quarter 2025 financial results and prov...
NFI schedules release of first quarter 2025 financial results and provides details about Annual and Special Meeting of Shareholders WINNIPEG, Manitoba, April 07, 2025 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI or the Company) a leader in propulsion-agnostic bus and coach mobility solutions, today announced the release date of its first quarter of 2025 (Q1 2025) financial results and notes that the Company’s Board of Directors (Board) has set the date for its Annual and Special Meeting of Shareholders for May 9, 2025 at 12:00 p.m. Eastern Time (ET). First ...
MasterCraft Boat Holdings, Inc. Announces CFO Transition
MasterCraft Boat Holdings, Inc. Announces CFO Transition VONORE, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”), today announced that Tim Oxley, Chief Financial Officer, has decided to retire from the Company, effective December 31, 2025. Scott Kent, Vice President of Finance, will succeed Mr. Oxley as Chief Financial Officer, effective July 1, 2025. Mr. Oxley will transition to serve as a special advisor to the executive team/Board from July 1, 2025 until December 31, 2025, to ensure a smooth transition of responsibilities. Mr....
Bombardier présentera ses résultats financiers du premier trimestre de...
Bombardier présentera ses résultats financiers du premier trimestre de 2025 et tiendra son assemblée générale annuelle des actionnaires le 1er mai 2025 MONTRÉAL, 07 avr. 2025 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) publiera ses résultats financiers du premier trimestre de 2025 le 1er mai 2025. Le même jour, Bombardier tiendra son assemblée générale annuelle des actionnaires (« Assemblée ») en format virtuel. Résultats financiers du premier trimestre de 2025 Éric Martel, président et chef de la direction de Bombardier, et Bart Demosky, vice-président exécutif et chef des fin...
Bombardier to Report First Quarter 2025 Financial Results and Hold Ann...
Bombardier to Report First Quarter 2025 Financial Results and Hold Annual General Meeting of Shareholders on May 1st, 2025 MONTREAL, April 07, 2025 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2025 on May 1st, 2025. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual format. Financial results for the first quarter of 2025 Éric Martel, President and Chief Executive Officer, Bombardier, and Bart Demosky, Executive Vice President and Chief Financial Officer, Bombardier...
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Med...
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis (MS) and the other detailing the experience of seven individuals with MS who switched to BRIUMVI® (ublituximab-xiiy) from a different anti-CD20 monoclonal antibody therapy due to efficacy or tolerability concerns. Details of the publications are provided below. Michael S. Weiss, the Company’s Executi...
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Direct...
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the Board of Directors, effective immediately. “On behalf of the board, I welcome Michael. His financial expertise, experience on other boards and, as a fellow shareholder, his shared priority to continue focusing on strategies to maximize shareholder value, make him a ...
Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Rev...
Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million CELEBRATION, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $150 million. “We have reached another key milestone with the closing on the sale of our PRV, which we received following the successful approval of MIPLYFFA...
Kenorland Announces Renewal of Normal Course Issuer Bid
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2025) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announced today that it has obtained the approval of the TSX Venture Exchange (the "TSXV") for a new normal course issuer bid (the "NCIB"). The NCIB will commence on April 10, 2025, and terminate on the earliest to occur of (i) April 9, 2026, (ii) the date on which the maximum number of Shares that can be acquired pursuant to the NCIB have been purchased, or (iii) such earlier date on which the Company provides notice of termination of t...
Nationgate Holdings Berhad: 2 directors
Two Directors at Nationgate Holdings Berhad bought 405,000 shares at between 1.148MYR and 1.270MYR. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directo...
Impact Biomedical Inc: 1 director
A director at Impact Biomedical Inc sold 1,689,693 shares at 0.665USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.